Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 9,488	$ 5,985	$ 20,251	$ 11,865
Acquired in-process research and development			23,049
General and administrative	4,064	2,858	7,581	5,673
Total operating expenses	13,552	8,843	50,881	17,538
Loss from operations	(13,552)	(8,843)	(50,881)	(17,538)
Other expense, net:
Interest expense	(259)	(270)	(515)	(541)
Interest income	64	13	90	39
Other expense, net	(382)	(58)	(240)	(109)
Total other expense, net	(577)	(315)	(665)	(611)
Net loss	(14,129)	(9,158)	(51,546)	(18,149)
Other comprehensive income (loss), net:
Unrealized loss on available-for-sale securities, net	(54)	(5)	(234)	(8)
Foreign currency translation gain	359	51	223	96
Total other comprehensive income (loss), net	305	46	(11)	88
Comprehensive loss	$ (13,824)	$ (9,112)	$ (51,557)	$ (18,061)
Net loss per share, basic	$ (0.41)	$ (0.31)	$ (1.56)	$ (0.64)
Net loss per share, diluted	$ (0.41)	$ (0.31)	$ (1.56)	$ (0.64)
Weighted-average number of common shares outstanding, basic	34,292,642	29,076,562	33,085,917	28,205,805
Weighted-average number of common shares outstanding, diluted	34,292,642	29,076,562	33,085,917	28,205,805